Annual FCF
$124.47 M
-$1.59 M-1.26%
31 December 2023
Summary:
Amedisys annual free cash flow is currently $124.47 million, with the most recent change of -$1.59 million (-1.26%) on 31 December 2023. During the last 3 years, it has fallen by -$57.70 million (-31.67%). AMED annual FCF is now -56.11% below its all-time high of $283.62 million, reached on 31 December 2020.AMED Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$104.03 M
+$53.30 M+105.05%
01 September 2024
Summary:
Amedisys quarterly free cash flow is currently $104.03 million, with the most recent change of +$53.30 million (+105.05%) on 01 September 2024. Over the past year, it has increased by +$45.82 million (+78.72%). AMED quarterly FCF is now -22.17% below its all-time high of $133.66 million, reached on 30 June 2020.AMED Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$203.54 M
+$115.07 M+130.07%
01 September 2024
Summary:
Amedisys TTM free cash flow is currently $203.54 million, with the most recent change of +$115.07 million (+130.07%) on 01 September 2024. Over the past year, it has increased by +$79.06 million (+63.52%). AMED TTM FCF is now -38.58% below its all-time high of $331.40 million, reached on 31 March 2021.AMED TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMED Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +78.7% | +63.5% |
| 3 y3 years | -31.7% | +2652.8% | +11.7% |
| 5 y5 years | -35.9% | +41.2% | +4.8% |
AMED Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.7% | at low | at high | +772.2% | at high | +130.1% |
| 5 y | 5 years | -56.1% | at low | -22.2% | +772.2% | -38.6% | +130.1% |
| alltime | all time | -56.1% | +260.5% | -22.2% | +212.3% | -38.6% | +325.2% |
Amedisys Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $104.03 M(+105.0%) | $203.54 M(+130.1%) |
| June 2024 | - | $50.73 M(-637.8%) | $88.47 M(-2.4%) |
| Mar 2024 | - | -$9.43 M(-116.2%) | $90.64 M(-27.2%) |
| Dec 2023 | $124.47 M(-1.3%) | $58.21 M(-627.2%) | $124.47 M(+18.4%) |
| Sept 2023 | - | -$11.04 M(-120.9%) | $105.12 M(+4.4%) |
| June 2023 | - | $52.91 M(+116.8%) | $100.69 M(-2.2%) |
| Mar 2023 | - | $24.40 M(-37.2%) | $102.99 M(-18.3%) |
| Dec 2022 | $126.07 M(-30.8%) | $38.85 M(-351.1%) | $126.07 M(+38.5%) |
| Sept 2022 | - | -$15.47 M(-128.0%) | $90.99 M(-45.1%) |
| June 2022 | - | $55.21 M(+16.3%) | $165.84 M(-6.4%) |
| Mar 2022 | - | $47.48 M(+1156.5%) | $177.27 M(-2.7%) |
| Dec 2021 | $182.17 M(-35.8%) | $3.78 M(-93.6%) | $182.17 M(-24.7%) |
| Sept 2021 | - | $59.38 M(-10.9%) | $241.97 M(-8.5%) |
| June 2021 | - | $66.63 M(+27.2%) | $264.38 M(-20.2%) |
| Mar 2021 | - | $52.38 M(-17.6%) | $331.40 M(+16.8%) |
| Dec 2020 | $283.62 M(+46.1%) | $63.58 M(-22.3%) | $283.62 M(-3.4%) |
| Sept 2020 | - | $81.79 M(-38.8%) | $293.71 M(+14.9%) |
| June 2020 | - | $133.66 M(+2804.9%) | $255.74 M(+42.2%) |
| Mar 2020 | - | $4.60 M(-93.8%) | $179.85 M(-7.3%) |
| Dec 2019 | $194.11 M(-10.5%) | $73.67 M(+68.2%) | $194.11 M(+5.7%) |
| Sept 2019 | - | $43.81 M(-24.2%) | $183.60 M(-10.1%) |
| June 2019 | - | $57.77 M(+206.3%) | $204.20 M(+3.7%) |
| Mar 2019 | - | $18.86 M(-70.1%) | $196.93 M(-9.2%) |
| Dec 2018 | $216.93 M(+128.3%) | $63.16 M(-1.9%) | $216.93 M(+17.7%) |
| Sept 2018 | - | $64.41 M(+27.5%) | $184.32 M(+43.5%) |
| June 2018 | - | $50.50 M(+30.0%) | $128.49 M(+15.6%) |
| Mar 2018 | - | $38.85 M(+27.2%) | $111.17 M(+17.0%) |
| Dec 2017 | $95.02 M(+104.2%) | $30.56 M(+256.3%) | $95.02 M(+4.6%) |
| Sept 2017 | - | $8.58 M(-74.2%) | $90.81 M(+6.3%) |
| June 2017 | - | $33.18 M(+46.1%) | $85.45 M(+34.1%) |
| Mar 2017 | - | $22.71 M(-13.8%) | $63.71 M(+36.9%) |
| Dec 2016 | $46.54 M(-46.1%) | $26.35 M(+719.2%) | $46.54 M(+26.5%) |
| Sept 2016 | - | $3.22 M(-71.9%) | $36.78 M(-41.6%) |
| June 2016 | - | $11.44 M(+106.4%) | $62.97 M(-20.8%) |
| Mar 2016 | - | $5.54 M(-66.6%) | $79.53 M(-7.9%) |
| Dec 2015 | $86.36 M(-211.4%) | $16.58 M(-43.6%) | $86.36 M(+19.5%) |
| Sept 2015 | - | $29.40 M(+5.0%) | $72.24 M(+7.2%) |
| June 2015 | - | $28.00 M(+126.3%) | $67.37 M(-226.4%) |
| Mar 2015 | - | $12.37 M(+401.0%) | -$53.30 M(-31.3%) |
| Dec 2014 | -$77.54 M(-228.1%) | $2.47 M(-89.9%) | -$77.54 M(-8.1%) |
| Sept 2014 | - | $24.53 M(-126.5%) | -$84.36 M(-6.7%) |
| June 2014 | - | -$92.67 M(+680.4%) | -$90.39 M(-443.6%) |
| Mar 2014 | - | -$11.87 M(+172.8%) | $26.31 M(-56.5%) |
| Dec 2013 | $60.53 M(+185.1%) | -$4.35 M(-123.5%) | $60.53 M(-6.1%) |
| Sept 2013 | - | $18.50 M(-23.1%) | $64.44 M(+15.6%) |
| June 2013 | - | $24.04 M(+7.6%) | $55.75 M(+30.0%) |
| Mar 2013 | - | $22.34 M(-5224.3%) | $42.88 M(+102.0%) |
| Dec 2012 | $21.23 M(-78.1%) | -$436.00 K(-104.4%) | $21.23 M(-59.7%) |
| Sept 2012 | - | $9.80 M(-12.3%) | $52.74 M(-9.3%) |
| June 2012 | - | $11.17 M(+1516.9%) | $58.18 M(-5.4%) |
| Mar 2012 | - | $691.00 K(-97.8%) | $61.51 M(-36.5%) |
| Dec 2011 | $96.80 M(-30.8%) | $31.07 M(+103.9%) | $96.80 M(+32.7%) |
| Sept 2011 | - | $15.24 M(+5.0%) | $72.95 M(-20.1%) |
| June 2011 | - | $14.51 M(-59.7%) | $91.26 M(-22.1%) |
| Mar 2011 | - | $35.97 M(+397.6%) | $117.21 M(-16.2%) |
| Dec 2010 | $139.93 M(-32.1%) | $7.23 M(-78.5%) | $139.93 M(-7.4%) |
| Sept 2010 | - | $33.55 M(-17.1%) | $151.07 M(-22.6%) |
| June 2010 | - | $40.45 M(-31.1%) | $195.21 M(-10.4%) |
| Mar 2010 | - | $58.69 M(+219.4%) | $217.77 M(+5.7%) |
| Dec 2009 | $206.09 M | $18.38 M(-76.3%) | $206.09 M(-13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $77.68 M(+23.3%) | $239.11 M(+31.6%) |
| June 2009 | - | $63.02 M(+34.1%) | $181.74 M(+26.0%) |
| Mar 2009 | - | $47.01 M(-8.6%) | $144.25 M(+22.6%) |
| Dec 2008 | $117.63 M(+82.5%) | $51.40 M(+153.1%) | $117.63 M(+63.4%) |
| Sept 2008 | - | $20.31 M(-20.5%) | $72.00 M(+0.6%) |
| June 2008 | - | $25.53 M(+25.3%) | $71.56 M(+25.5%) |
| Mar 2008 | - | $20.38 M(+252.8%) | $57.03 M(-11.5%) |
| Dec 2007 | $64.45 M(+366.7%) | $5.78 M(-70.9%) | $64.45 M(-3.1%) |
| Sept 2007 | - | $19.87 M(+80.6%) | $66.52 M(+31.9%) |
| June 2007 | - | $11.00 M(-60.4%) | $50.42 M(-4.5%) |
| Mar 2007 | - | $27.81 M(+254.7%) | $52.79 M(+282.3%) |
| Dec 2006 | $13.81 M(-40.3%) | $7.84 M(+108.0%) | $13.81 M(-11.3%) |
| Sept 2006 | - | $3.77 M(-71.8%) | $15.56 M(-34.2%) |
| June 2006 | - | $13.38 M(-219.7%) | $23.64 M(+244.5%) |
| Mar 2006 | - | -$11.18 M(-216.5%) | $6.86 M(-70.4%) |
| Dec 2005 | $23.15 M(-5.4%) | $9.59 M(-19.1%) | $23.15 M(+35.9%) |
| Sept 2005 | - | $11.85 M(-447.9%) | $17.03 M(+46.3%) |
| June 2005 | - | -$3.41 M(-166.7%) | $11.64 M(-42.2%) |
| Mar 2005 | - | $5.11 M(+46.9%) | $20.13 M(-17.8%) |
| Dec 2004 | $24.48 M(+22.4%) | $3.48 M(-46.1%) | $24.48 M(-9.0%) |
| Sept 2004 | - | $6.46 M(+27.2%) | $26.89 M(+16.8%) |
| June 2004 | - | $5.08 M(-46.3%) | $23.03 M(-5.5%) |
| Mar 2004 | - | $9.46 M(+60.8%) | $24.38 M(+21.9%) |
| Dec 2003 | $20.00 M(+67.4%) | $5.89 M(+126.7%) | $20.00 M(+35.1%) |
| Sept 2003 | - | $2.60 M(-59.6%) | $14.80 M(+5.3%) |
| June 2003 | - | $6.43 M(+26.5%) | $14.06 M(+32.7%) |
| Mar 2003 | - | $5.08 M(+639.1%) | $10.60 M(-11.3%) |
| Dec 2002 | $11.95 M(-200.6%) | $688.00 K(-63.0%) | $11.95 M(+147.8%) |
| Sept 2002 | - | $1.86 M(-37.4%) | $4.82 M(+664.2%) |
| June 2002 | - | $2.97 M(-53.9%) | $631.00 K(-108.8%) |
| Mar 2002 | - | $6.43 M(-199.9%) | -$7.14 M(-39.9%) |
| Dec 2001 | -$11.88 M(-280.6%) | -$6.44 M(+176.0%) | -$11.88 M(-534.5%) |
| Sept 2001 | - | -$2.33 M(-51.4%) | $2.73 M(-29.6%) |
| June 2001 | - | -$4.80 M(-383.4%) | $3.89 M(-42.5%) |
| Mar 2001 | - | $1.69 M(-79.3%) | $6.76 M(+2.7%) |
| Dec 2000 | $6.58 M(-165.0%) | $8.17 M(-792.0%) | $6.58 M(-512.0%) |
| Sept 2000 | - | -$1.18 M(-38.7%) | -$1.60 M(+284.6%) |
| June 2000 | - | -$1.93 M(-227.4%) | -$415.00 K(-127.4%) |
| Mar 2000 | - | $1.51 M(-118.6%) | $1.51 M(-112.3%) |
| Dec 1999 | -$10.12 M(+40.1%) | - | - |
| Mar 1999 | - | -$8.13 M(-227.6%) | -$12.26 M(+69.7%) |
| Dec 1998 | -$7.23 M(+178.1%) | $6.37 M(-199.6%) | -$7.23 M(-55.7%) |
| Sept 1998 | - | -$6.40 M(+56.1%) | -$16.30 M(+77.2%) |
| June 1998 | - | -$4.10 M(+32.3%) | -$9.20 M(+84.0%) |
| Mar 1998 | - | -$3.10 M(+14.9%) | -$5.00 M(+92.4%) |
| Dec 1997 | -$2.60 M(-33.4%) | -$2.70 M(-485.4%) | -$2.60 M(-13.4%) |
| Sept 1997 | - | $700.00 K(+600.0%) | -$3.00 M(+57.9%) |
| June 1997 | - | $100.00 K(-114.3%) | -$1.90 M(-42.4%) |
| Mar 1997 | - | -$700.00 K(-77.4%) | -$3.30 M(-15.4%) |
| Dec 1996 | -$3.90 M(-425.0%) | -$3.10 M(-272.2%) | -$3.90 M(+160.0%) |
| Sept 1996 | - | $1.80 M(-238.5%) | -$1.50 M(-28.6%) |
| June 1996 | - | -$1.30 M(0.0%) | -$2.10 M(-1150.0%) |
| Mar 1996 | - | -$1.30 M(+85.7%) | $200.00 K(-83.3%) |
| Dec 1995 | $1.20 M(-166.7%) | -$700.00 K(-158.3%) | $1.20 M(-36.8%) |
| Sept 1995 | - | $1.20 M(+20.0%) | $1.90 M(+171.4%) |
| June 1995 | - | $1.00 M(-433.3%) | $700.00 K(-275.0%) |
| Mar 1995 | - | -$300.00 K(+200.0%) | -$400.00 K(-60.0%) |
| Dec 1994 | -$1.80 M(+260.0%) | - | - |
| June 1994 | - | -$100.00 K(-88.9%) | -$1.00 M(+11.1%) |
| Mar 1994 | - | -$900.00 K | -$900.00 K |
| Dec 1993 | -$500.00 K | - | - |
FAQ
- What is Amedisys annual free cash flow?
- What is the all time high annual FCF for Amedisys?
- What is Amedisys quarterly free cash flow?
- What is the all time high quarterly FCF for Amedisys?
- What is Amedisys quarterly FCF year-on-year change?
- What is Amedisys TTM free cash flow?
- What is the all time high TTM FCF for Amedisys?
- What is Amedisys TTM FCF year-on-year change?
What is Amedisys annual free cash flow?
The current annual FCF of AMED is $124.47 M
What is the all time high annual FCF for Amedisys?
Amedisys all-time high annual free cash flow is $283.62 M
What is Amedisys quarterly free cash flow?
The current quarterly FCF of AMED is $104.03 M
What is the all time high quarterly FCF for Amedisys?
Amedisys all-time high quarterly free cash flow is $133.66 M
What is Amedisys quarterly FCF year-on-year change?
Over the past year, AMED quarterly free cash flow has changed by +$45.82 M (+78.72%)
What is Amedisys TTM free cash flow?
The current TTM FCF of AMED is $203.54 M
What is the all time high TTM FCF for Amedisys?
Amedisys all-time high TTM free cash flow is $331.40 M
What is Amedisys TTM FCF year-on-year change?
Over the past year, AMED TTM free cash flow has changed by +$79.06 M (+63.52%)